Federated Hermes Inc. Trims Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Federated Hermes Inc. lessened its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 1.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 148,017 shares of the medical device company’s stock after selling 2,014 shares during the period. Federated Hermes Inc. owned about 0.07% of Cooper Companies worth $13,607,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Byrne Asset Management LLC acquired a new stake in Cooper Companies in the 4th quarter valued at approximately $33,000. OFI Invest Asset Management acquired a new stake in Cooper Companies in the 4th quarter valued at approximately $34,000. New Age Alpha Advisors LLC acquired a new position in shares of Cooper Companies in the fourth quarter worth $38,000. West Financial Advisors LLC acquired a new position in shares of Cooper Companies in the fourth quarter worth $49,000. Finally, Atala Financial Inc acquired a new position in shares of Cooper Companies in the fourth quarter worth $51,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have commented on COO shares. JPMorgan Chase & Co. dropped their price target on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Friday, March 7th. BNP Paribas upgraded shares of Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Citigroup dropped their price target on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Friday, March 7th. Finally, Robert W. Baird dropped their price target on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a research note on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Stock Performance

Shares of COO stock opened at $77.90 on Thursday. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The firm has a fifty day moving average price of $85.39 and a 200 day moving average price of $95.08. The company has a market cap of $15.58 billion, a P/E ratio of 39.95, a PEG ratio of 2.25 and a beta of 1.01. The Cooper Companies, Inc. has a 12 month low of $69.81 and a 12 month high of $112.38.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.